Wells Pharmacy Network LLC

FDA inspection history across 2 sites, 2013 to 2018

5
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2013: one Form 483; 2014: two Form 483s and one warning letter; 2016: one Form 483; 2018: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2013–18Five Form 483s and one warning letter, at Ocala, Florida and Wellington, Florida.
  2. 2014The longest 483 on file: 13 observations over 5 pages at Ocala, Florida.

Cited most

Across all Wells Pharmacy Network observations on file

The complete Wells Pharmacy Network file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Documents

6 on file, newest first
DateDocumentPrice
2018-06-22483 Form 483$99
2016-09-13483 Form 483$99
2014-11-10Warning letter Warning letter$99
2014-06-19483 Form 483$99
2014-03-07483 Form 483$99
2013-07-26483 Form 483$99

FEI number 3006228598 · most recent document Jun 22, 2018

About Wells Pharmacy Network LLC

How many FDA Form 483s has Wells Pharmacy Network LLC received?

FDA Intel has 5 Form 483s on file for Wells Pharmacy Network LLC; the most recent is dated Jun 22, 2018.

When was Wells Pharmacy Network LLC last inspected by FDA?

The most recent FDA inspection document on file for Wells Pharmacy Network LLC is a Form 483 dated Jun 22, 2018, for the site in Ocala, Florida.

What did FDA cite at Wells Pharmacy Network LLC?

The regulations cited most in the observations on file for Wells Pharmacy Network LLC are 21 CFR 211.42 (Design and construction features), 13 times; 21 CFR 211.113 (Control of microbiological contamination), 5 times; 21 CFR 211.166 (Stability testing), 4 times.

Has Wells Pharmacy Network LLC received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Wells Pharmacy Network LLC; the most recent is dated Nov 10, 2014.

Wells Pharmacy Network LLC FDA Inspection History & 483s · FDA Intel